Post-approval studies (Phase 4)WithdrawnNCT02234869
What this trial is testing
Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy
Who this might be right for
Relapsing Multiple Sclerosis
Biogen
Showing 10 of 10 results